Rahul Reddy
Retina Specialist · Phoenix, AZNPI 1083806863
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (43.3%), royalties or licence payments and other — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by US Retina LLC at 24.8% of the total. Reporting peaked in 2019 at $82,227 and has fallen 76.8% since, to $19,064 in 2025. Among retina specialist clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 229 payments — averaging $1453.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- US Retina LLC$83K
- Bausch & Lomb Americas Inc.$55K
- Regeneron Healthcare Solutions, Inc.$44K
- Novartis$40K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$36K
- Eyepoint US, Inc.$35K
- plus $40K from 8 others
Across 31 payments — averaging $8002.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$100K
- Regeneron$63K
- Apellis Pharmaceuticals, Inc.$57K
- Novartis$23K
- Eyepoint US, Inc.$6K
- AbbVie$90
What the payments were for
- Royalty or licence$66,89520%
- Consulting fees$17,6485%
- Speaking & faculty fees$144,09843%
- Travel & lodging$14,6214%
- Food & beverage$6,9912%
- Education$980%
- Gifts$190%
- Ownership interest$32,38310%
- Other$50,00015%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| US Retina LLC | 8 | $82,547 |
| Bausch & Lomb Americas Inc. | 16 | $55,058 |
| Regeneron Healthcare Solutions, Inc. | 32 | $44,097 |
| Novartis | 45 | $40,220 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 35 | $35,620 |
| Eyepoint US, Inc. | 27 | $35,134 |
| AbbVie(2 entities) | 38 | $28,956 |
| Alimera Sciences, Inc. | 14 | $10,172 |
| Carl Zeiss Meditec, Inc. | 4 | $297 |
| Dutch Ophthalmic, USA | 2 | $280 |
| Genentech USA, Inc. | 5 | $241 |
| Genentech, Inc. | 1 | $97 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Alcon | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPHTHALMIC INSTRUMENTS$87,436
- EYLEA$43,705
- YUTIQ$34,468
- OZURDEX$28,370
- STELLARIS PC$19,058
- BEOVU$15,583
- VITESSE$10,986
- Iluvien$9,908
- LIGHT PIPES$9,486
- EVA Ophthalmic Surgical System$280
- DEXYCU$248
How this compares
$332,753 in reported general payments places this provider in the 95th percentile of 30 retina specialist providers in Arizona.
Other retina specialist in Phoenix
- Jordan GraffPhoenix$483K
- Henry KwongPhoenix$147K
- Benjamin BakallPhoenix$137K
- Jaime GaitanPhoenix$114K
- Stephen de SouzaPhoenix$95K
- Joseph BryanPhoenix$88K
- Alan GordonPhoenix$86K
- Suhail AlamPhoenix$24K
- Rima PatelPhoenix$19K
- Matthew WelchPhoenix$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.